Mateon Therapeutics (OTCQB: MATN) Submits to BARDA to be funded to accelerate their OT-101 as COVID-19 Cure.

https://t.co/uXqAzNz5cO

$XYN $REGN $RGNX $BMY $LLY $ABT $PG $AMGN

#CoronaVirusVaccine #HotStocks #StockMarket #Daytrade #Profit #EmergingGrowth #HighRiskHighReturns